106 related articles for article (PubMed ID: 9571033)
1. The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis.
Ruf A; Rolli V; de Murcia G; Schulz GE
J Mol Biol; 1998 Apr; 278(1):57-65. PubMed ID: 9571033
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for lack of ADP-ribosyltransferase activity in poly(ADP-ribose) polymerase-13/zinc finger antiviral protein.
Karlberg T; Klepsch M; Thorsell AG; Andersson CD; Linusson A; Schüler H
J Biol Chem; 2015 Mar; 290(12):7336-44. PubMed ID: 25635049
[TBL] [Abstract][Full Text] [Related]
3. Structures of 3-acetylpyridine adenine dinucleotide and ADP-ribose bound to the electron input module of respiratory complex I.
Wohlwend D; Mérono L; Bucka S; Ritter K; Jessen HJ; Friedrich T
Structure; 2024 Jun; 32(6):715-724.e3. PubMed ID: 38503292
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of Stable NAD
Madern JM; Kim RQ; Misra M; Dikic I; Zhang Y; Ovaa H; Codée JDC; Filippov DV; van der Heden van Noort GJ
Chembiochem; 2020 Oct; 21(20):2903-2907. PubMed ID: 32421893
[TBL] [Abstract][Full Text] [Related]
5. System-wide identification and prioritization of enzyme substrates by thermal analysis.
Saei AA; Beusch CM; Sabatier P; Wells JA; Gharibi H; Meng Z; Chernobrovkin A; Rodin S; Näreoja K; Thorsell AG; Karlberg T; Cheng Q; Lundström SL; Gaetani M; Végvári Á; Arnér ESJ; Schüler H; Zubarev RA
Nat Commun; 2021 Feb; 12(1):1296. PubMed ID: 33637753
[TBL] [Abstract][Full Text] [Related]
6. Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP.
Frigon L; Pascal JM
Nucleic Acids Res; 2023 Dec; 51(22):12492-12507. PubMed ID: 37971310
[TBL] [Abstract][Full Text] [Related]
7. ADP-ribosylation from molecular mechanisms to therapeutic implications.
Suskiewicz MJ; Prokhorova E; Rack JGM; Ahel I
Cell; 2023 Oct; 186(21):4475-4495. PubMed ID: 37832523
[TBL] [Abstract][Full Text] [Related]
8. The Role of Poly(ADP-ribose) Polymerase 1 in Nuclear and Mitochondrial Base Excision Repair.
Herrmann GK; Yin YW
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627260
[TBL] [Abstract][Full Text] [Related]
9. Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs.
Nizi MG; Sarnari C; Tabarrini O
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570820
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Biomolecular Condensates by Poly(ADP-ribose).
Rhine K; Odeh HM; Shorter J; Myong S
Chem Rev; 2023 Jul; 123(14):9065-9093. PubMed ID: 37115110
[TBL] [Abstract][Full Text] [Related]
11. PARP1pred: a web server for screening the bioactivity of inhibitors against DNA repair enzyme PARP-1.
Lerksuthirat T; Chitphuk S; Stitchantrakul W; Dejsuphong D; Malik AA; Nantasenamat C
EXCLI J; 2023; 22():84-107. PubMed ID: 36814851
[TBL] [Abstract][Full Text] [Related]
12. [1,2,4]Triazolo[3,4-
Murthy S; Nizi MG; Maksimainen MM; Massari S; Alaviuhkola J; Lippok BE; Vagaggini C; Sowa ST; Galera-Prat A; Ashok Y; Venkannagari H; Prunskaite-Hyyryläinen R; Dreassi E; Lüscher B; Korn P; Tabarrini O; Lehtiö L
J Med Chem; 2023 Jan; 66(2):1301-1320. PubMed ID: 36598465
[TBL] [Abstract][Full Text] [Related]
13. Human PARP1 Facilitates Transcription through a Nucleosome and Histone Displacement by Pol II In Vitro.
Kotova EY; Hsieh FK; Chang HW; Maluchenko NV; Langelier MF; Pascal JM; Luse DS; Feofanov AV; Studitsky VM
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806109
[TBL] [Abstract][Full Text] [Related]
14. Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.
Nizi MG; Maksimainen MM; Lehtiö L; Tabarrini O
J Med Chem; 2022 Jun; 65(11):7532-7560. PubMed ID: 35608571
[TBL] [Abstract][Full Text] [Related]
15. The zinc-binding motif in tankyrases is required for the structural integrity of the catalytic ADP-ribosyltransferase domain.
Sowa ST; Lehtiö L
Open Biol; 2022 Mar; 12(3):210365. PubMed ID: 35317661
[TBL] [Abstract][Full Text] [Related]
16. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
[TBL] [Abstract][Full Text] [Related]
17. Activation of PARP2/ARTD2 by DNA damage induces conformational changes relieving enzyme autoinhibition.
Obaji E; Maksimainen MM; Galera-Prat A; Lehtiö L
Nat Commun; 2021 Jun; 12(1):3479. PubMed ID: 34108479
[TBL] [Abstract][Full Text] [Related]
18. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
[TBL] [Abstract][Full Text] [Related]
19. PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis.
Wasyluk W; Zwolak A
J Inflamm Res; 2021; 14():1827-1844. PubMed ID: 33986609
[TBL] [Abstract][Full Text] [Related]
20. PARP1: Structural insights and pharmacological targets for inhibition.
Spiegel JO; Van Houten B; Durrant JD
DNA Repair (Amst); 2021 Jul; 103():103125. PubMed ID: 33940558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
